thalidomide has been researched along with palbociclib in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
An, Z; Chandarlapaty, S; Deng, H; Gao, H; Li, Q; Rao, Y; Su, S; Wang, J; Wu, W; Yang, H; Yang, Z; Zhu, S | 1 |
1 other study(ies) available for thalidomide and palbociclib
Article | Year |
---|---|
Potent and Preferential Degradation of CDK6 via Proteolysis Targeting Chimera Degraders.
Topics: Angiogenesis Inhibitors; Cell Line, Tumor; Cell Proliferation; Cyclin-Dependent Kinase 6; Hematologic Neoplasms; HL-60 Cells; Humans; Molecular Structure; Piperazines; Protein Kinase Inhibitors; Proteolysis; Pyridines; Small Molecule Libraries; Thalidomide; THP-1 Cells; Ubiquitin-Protein Ligases | 2019 |